Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
AMNEAL PHARMACEUTICALS, INC. (AMRX) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
$784.51M |
|
$2.37M |
|
$510.54M |
|
$273.97M |
|
$714.17M |
|
$70.34M |
|
$-75.57M |
|
$-5.22M |
|
$-5.22M |
|
$18.13M |
|
$18.13M |
|
$18.13M |
|
$18.13M |
|
$70.34M |
|
$129.45M |
|
314.17M |
|
324.75M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$1.84B |
|
$434.99M |
|
$1.76B |
|
$3.60B |
|
$862.11M |
|
$2.57B |
|
$2.85B |
|
$3.71B |
|
$-109.95M |
|
$-1.29B |
|
$-109.95M |
|
314.31M |
|
| Cash Flow Statement Financials | |
$209.68M |
|
$-66.81M |
|
$-21.41M |
|
$118.42M |
|
$238.41M |
|
$119.99M |
|
$23.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.13 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
1.04 |
|
-23.41 |
|
34.92% |
|
8.97% |
|
8.97% |
|
-- |
|
-0.67% |
|
0.30% |
|
$155.38M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.83 |
|
0.89 |
|
101.70 |
|
-16.49% |
|
-1.40% |
|
0.50% |
|
0.74% |
|
$-0.35 |
|
$0.48 |
|
$0.65 |
|